Now Is A Suitable Moment For A Long-Term Purchase Of Akero Therapeutics Inc (NASDAQ: AKRO)
Currently, there are 69.43M common shares owned by the public and among those 58.04M shares have been available to trade. The company’s stock has a 5-day price change of -0.95% and 44.53% over the past three months. AKRO shares are trading 16.49% year to date (YTD), with the 12-month market performance down to -45.28% lower. […]
Akero Therapeutics Inc (AKRO): A Great Stock For Handling Current Market Conditions?
Currently, there are 55.71M common shares owned by the public and among those 50.08M shares have been available to trade. Insiders at the company have transacted a total of 73 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 20 of these insider trades were purchases, […]
